Literature DB >> 26456392

Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.

Bastiaan J Venhuis1, Peter H J Keizers1, Rüdiger Klausmann2, Ingrid Hegger1.   

Abstract

Operation Pangea is an annual international week of action combating pharmaceutical crime. In this study, called Operation Resistance, we asked the national agencies in Europe to search for falsified antibiotics and biopharmaceutical injectables (peptides and proteins) amongst the medicines seized in Pangea 7 (2014). Reports were received from Belgium, Cyprus, Czech Republic, Denmark, France, the Netherlands, Portugal, Sweden, Spain, the United Kingdom, Norway, and Switzerland. The countries reported seizing about 21,000 dose units (e.g. tablets, capsules) of falsified antibiotics in total. Most of the antibiotics were unlicensed medicines with common antibiotic drugs. In this study week, very few falsified biopharmaceutical injectables were reported. Laboratories reported human growth hormone, sermorelin, melanotan II, and no active ingredients. The average shipment size seemed too large for personal use indicating that a substantial part was intended for resale. This study provides a snapshot of the falsified antibiotics and biopharmaceuticals that enter European countries. How much is actually reaching users during Pangea week - in on other weeks - remains unknown. The shipment sizes indicate falsified antibiotics and biopharmaceuticals are imported for both personal use and resale. The use of antibiotics from unreliable sources is a health risk, contributes to antimicrobial resistance, and may obscure a source of infection from health agencies. The falsified biopharmaceuticals are a health risk because they lack all labelling and may contain unlicensed drugs for injection. It seems important to raise awareness among health-care professionals that falsified medicines in Europe are not restricted to erectile dysfunction drugs.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Pangea; antibiotics; antimicrobal resistance; biopharmaceutical; counterfeit medicines; falsified medicines; peptide injectables

Mesh:

Substances:

Year:  2015        PMID: 26456392     DOI: 10.1002/dta.1888

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  3 in total

1.  Health Care Providers' Knowledge, Attitude and Practice Toward Counterfeit Medicines in Mizan-Tepi University Teaching Hospital, South West Ethiopia: A Cross-Sectional Study.

Authors:  Jafer Siraj; Abzayou Gebre; Miftah Shafi; Abdella Birhan; Fikadu Ejeta; Solomon Hambisa
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

2.  Medicine quality in high-income countries: The obstacles to comparative prevalence studies.

Authors:  Bernard David Naughton; Ebru Akgul
Journal:  Med Access Point Care       Date:  2021-10-21

3.  A systematic review of substandard, falsified, unlicensed and unregistered medicine sampling studies: a focus on context, prevalence, and quality.

Authors:  Dominic McManus; Bernard David Naughton
Journal:  BMJ Glob Health       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.